These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14654945)

  • 1. Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma.
    Hayashi N; Nakamori S; Hiraoka N; Tsujie M; Xundi X; Takano T; Amino N; Sakon M; Monden M
    Int J Oncol; 2004 Jan; 24(1):89-95. PubMed ID: 14654945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C; Liu H; Posch MG; Waechter M; Facklam M; Fenner MH; Ruthardt M; Possinger K; Phillip Koeffler H; Elstner E
    Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
    Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
    J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
    Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
    Burgermeister E; Tencer L; Liscovitch M
    Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
    Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
    J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of PPARgamma ligands on the proliferation and apoptosis of human melanoma cells.
    Placha W; Gil D; Dembińska-Kieć A; Laidler P
    Melanoma Res; 2003 Oct; 13(5):447-56. PubMed ID: 14512786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.
    Yuan J; Takahashi A; Masumori N; Uchida K; Hisasue S; Kitamura H; Itoh N; Tsukamoto T
    Urology; 2005 Mar; 65(3):594-9. PubMed ID: 15780399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
    Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
    Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
    Fujii D; Yoshida K; Tanabe K; Hihara J; Toge T
    Anticancer Res; 2004; 24(3a):1409-16. PubMed ID: 15274302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.
    Leung WK; Bai AH; Chan VY; Yu J; Chan MW; To KF; Wu JR; Chan KK; Fu YG; Chan FK; Sung JJ
    Gut; 2004 Mar; 53(3):331-8. PubMed ID: 14960510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.
    Takashima T; Fujiwara Y; Higuchi K; Arakawa T; Yano Y; Hasuma T; Otani S
    Int J Oncol; 2001 Sep; 19(3):465-71. PubMed ID: 11494023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells.
    Nakashiro KI; Hayashi Y; Kita A; Tamatani T; Chlenski A; Usuda N; Hattori K; Reddy JK; Oyasu R
    Am J Pathol; 2001 Aug; 159(2):591-7. PubMed ID: 11485917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells.
    Clay CE; Namen AM; Atsumi G; Trimboli AJ; Fonteh AN; High KP; Chilton FH
    J Investig Med; 2001 Sep; 49(5):413-20. PubMed ID: 11523697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.
    Kato M; Kusumi T; Tsuchida S; Tanaka M; Sasaki M; Kudo H
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):73-9. PubMed ID: 14634802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-gamma.
    Nishida K; Furumatsu T; Takada I; Kawai A; Yoshida A; Kunisada T; Inoue H
    Br J Cancer; 2002 Apr; 86(8):1303-9. PubMed ID: 11953889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
    Yoshimura R; Matsuyama M; Hase T; Tsuchida K; Kuratsukuri K; Kawahito Y; Sano H; Segawa Y; Nakatani T
    Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
    Inoue K; Kawahito Y; Tsubouchi Y; Kohno M; Yoshimura R; Yoshikawa T; Sano H
    Biochem Biophys Res Commun; 2001 Sep; 287(3):727-32. PubMed ID: 11563856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells.
    Nikitakis NG; Siavash H; Hebert C; Reynolds MA; Hamburger AW; Sauk JJ
    Br J Cancer; 2002 Dec; 87(12):1396-403. PubMed ID: 12454768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.